| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |